Expression Analysis Announces New Grant Initiative
News Sep 30, 2009
Dedicated to a deeper understanding of human health and disease, the grant will award four deserving researchers access to Expression Analysis’ state-of-the-art services. Four grants will be awarded; two focusing on genome-wide association studies and two on follow-up to GWAS. Included in all four grants is data analysis through digenysis™ a proprietary analysis tool that simultaneously analyzes allelic and copy number variation, accomplishing in days what can typically take months.
“Genomic technologies play a key role in the diagnosis, treatment and management of complex diseases and, to effectively tackle diseases we need to encourage the best and brightest minds to take risks on novel ideas. Our grant initiative is designed to further research in efforts to identify genetic elements important to human health and disease,” stated Steve McPhail, CEO of Expression Analysis.
Interested parties are encouraged to apply through the company’s website: www.ExpressionAnalysis.com/Grant - applications will be accepted through December 1, 2009.
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Researchers Find a Way to Separate Side Effects of Opioid Drugs Reducing RiskNews
Scientists have discovered a way to separate these two effects -- pain relief and breathing, opening a window of opportunity to make effective pain medications without the risk of respiratory failure.READ MORE
Computer Program Helps Find Ways to Repurpose Existing DrugsNews
Researchers have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts potential drug efficacy.READ MORE